Bococizumab (RN316)
Aug 10, 2015
New Approach Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors
Introduction: Cardiovascular disease is the leading cause of mortality worldwide due to increased level of Low Density Lipoprotein, cholesterol, which is a major modifiable risk factor. One of the risk factors is atherosclerosis caused when high levels of LDL-C in the blood build up in the inner walls of arteries, t...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
